India to United States: Fexofenadine Export Trade Route

The India to United States Fexofenadine corridor is one of India's established pharmaceutical export routes, with 302 shipments documented worth a combined $24.3M USD. The route is dominated by GRANULES INDIA LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's fexofenadine manufacturing sector.

Across 11 active suppliers, the average shipment value stands at $80.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with fexofenadine's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 33.4%, placing it at rank #9 among India's top fexofenadine export destinations globally.

On the import side, key buyers of Indian fexofenadine in United States include GRANULES CONSUMER HEALTH, GRANULES USA INC, GRANULES USA INC. and 38 others. GRANULES CONSUMER HEALTH is the single largest importer with 78 shipments valued at $5.8M USD.

India's fexofenadine exports to United States are driven primarily by a handful of large-scale manufacturers. GRANULES INDIA LIMITED with 171 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GRANULES INDIA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR REDDYS LABORATORIES LIMITED — together account for 85% of total trade value on this route. The average shipment value of $80.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as fexofenadine hydrochloride tablets usp and fexofenadine hydrochloride tablets, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, GRANULES CONSUMER HEALTH is the largest importer with 78 shipments worth $5.8M USD — representing 24% of all fexofenadine imports from India on this route. A total of 41 buyers are active on this corridor.